Sofie Pattijn

ImmunXperts SA provides risk assesment services to the pharmaceutical industy. It offers services to support client in the risk assessment and mitigation of drug candidate’s immunogenicity profile. The firm provides package to its customers, allowing to outsource the full immunogenicity assessment, or to cherry-pick the solutions or technologies needed/that fit client's exact requirements. The company was founded by Sofie Pattijn, Philippe Stas and Arno Kromminga in 2014 and is headquartered in Charleroi, Belgium.

ImmunXperts SA provides risk assesment services to the pharmaceutical industy. It offers services to support client in the risk assessment and mitigation of drug candidate’s immunogenicity profile. The firm provides package to its customers, allowing to outsource the full immunogenicity assessment, or to cherry-pick the solutions or technologies needed/that fit client's exact requirements. The company was founded by Sofie Pattijn, Philippe Stas and Arno Kromminga in 2014 and is headquartered in Charleroi, Belgium.

ImmunXperts SA provides risk assesment services to the pharmaceutical industy. It offers services to support client in the risk assessment and mitigation of drug candidate’s immunogenicity profile. The firm provides package to its customers, allowing to outsource the full immunogenicity assessment, or to cherry-pick the solutions or technologies needed/that fit client's exact requirements. The company was founded by Sofie Pattijn, Philippe Stas and Arno Kromminga in 2014 and is headquartered in Charleroi, Belgium.

ImmunXperts SA provides risk assesment services to the pharmaceutical industy. It offers services to support client in the risk assessment and mitigation of drug candidate’s immunogenicity profile. The firm provides package to its customers, allowing to outsource the full immunogenicity assessment, or to cherry-pick the solutions or technologies needed/that fit client's exact requirements. The company was founded by Sofie Pattijn, Philippe Stas and Arno Kromminga in 2014 and is headquartered in Charleroi, Belgium.